Macquarie Group’s Cellectis CLLS Stock Holding History

Macquarie Group’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-226,875	Closed	-$647K	–	985
2025 Q3	$647K	Hold	226,875	–	–	﹤0.01%	1385
2025 Q2	$343K	Hold	226,875	–	–	﹤0.01%	1503
2025 Q1	$281K	Hold	226,875	–	–	﹤0.01%	1521
2024 Q4	$408K	Hold	226,875	–	–	﹤0.01%	1461
2024 Q3	$486K	Hold	226,875	–	–	﹤0.01%	1481
2024 Q2	$424K	Hold	226,875	–	–	﹤0.01%	1485
2024 Q1	$601K	Hold	226,875	–	–	﹤0.01%	1428
2023 Q4	$699K	Hold	226,875	–	–	﹤0.01%	1435
2023 Q3	$358K	Hold	226,875	–	–	﹤0.01%	1474
2023 Q2	$447K	Hold	226,875	–	–	﹤0.01%	1473
2023 Q1	$438K	Hold	226,875	–	–	﹤0.01%	1484
2022 Q4	$476K	Hold	226,875	–	–	﹤0.01%	1521
2022 Q3	$520K	Hold	226,875	–	–	﹤0.01%	1523
2022 Q2	$642K	Hold	226,875	–	–	﹤0.01%	1562
2022 Q1	$1.03K	Hold	226,875	–	–	﹤0.01%	1543
2021 Q4	$1.84M	Hold	226,875	–	–	﹤0.01%	1396
2021 Q3	$2.86M	Hold	226,875	–	–	﹤0.01%	1263
2021 Q2	$3.51M	Hold	226,875	–	–	﹤0.01%	1236
2021 Q1	$4.58M	Hold	226,875	–	–	0.01%	936
2020 Q4	$6.14M	Hold	226,875	–	–	0.01%	834
2020 Q3	$4.2M	Buy	226,875 +7,200	+3%	+$128K	0.01%	872
2020 Q2	$3.91M	Hold	219,675	–	–	0.01%	847
2020 Q1	$2.02M	Hold	219,675	–	–	﹤0.01%	903
2019 Q4	$3.76M	Hold	219,675	–	–	0.01%	877
2019 Q3	$2.29M	Hold	219,675	–	–	﹤0.01%	982
2019 Q2	$3.43M	Hold	219,675	–	–	0.01%	866
2019 Q1	$4.03M	Hold	219,675	–	–	0.01%	837
2018 Q4	$3.66M	Buy	219,675 +28,688	+15%	+$665K	0.01%	827
2018 Q3	$5.39M	Buy	+190,987	New	+$5.49M	0.01%	765

Other funds holding CLLS

BGI

B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Macquarie Group's CLLS Position: Q4 2025 in Review

Macquarie Group sold out of Cellectis (CLLS) in Q4 2025, closing a stake of 226,875 shares — an estimated $647K sold.

Macquarie Group first reported a position in CLLS in Q3 2018 and held it in 29 quarters. The position peaked at $6.14M in Q4 2020. 34 funds tracked by Wall St. Rank hold CLLS as of Q4 2025.

Macquarie Group reported no remaining Cellectis position as of Q4 2025 after selling out during the quarter.
Macquarie Group sold 226,875 Cellectis shares in Q4 2025, an estimated $647K.
Macquarie Group first reported a position in Cellectis in Q3 2018 and held it in 29 quarters.
Macquarie Group's Cellectis position peaked at $6.14M in Q4 2020.
34 funds tracked by Wall St. Rank held Cellectis as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.